Page 44 - Read Online
P. 44
Page 6 of 8 Rigamonti et al. Vessel Plus 2021;5:47 https://dx.doi.org/10.20517/2574-1209.2021.65
pathophysiological, diagnostic, and therapeutic implications. Acta Neurochir (Wien) 1988;92:100-5. DOI PubMed
23. Rigamonti D, Pappas CT, Spetzler RF, Johnson PC. Extracerebral cavernous angiomas of the middle fossa. Neurosurgery
1990;27:306-10. DOI PubMed
24. Smith ER, Michael Scott R, Rigamonti D. Surgical treatment of cavernous malformations in children. In: Rigamonti D, editor.
Cavernous malformations of the nervous system. Cambridge: Cambridge University Press; 2011. p. 135-42. DOI
25. Rigamonti D, Spetzler RF, Drayer BP, et al. Appearance of venous malformations on magnetic resonance imaging. J Neurosurg
1988;69:535-9. DOI PubMed
26. Rigamonti D, Spetzler RF, Medina M, Rigamonti K, Geckle DS, Pappas C. Cerebral venous malformations. J Neurosurg 1990;73:560-
4. DOI PubMed
27. Rigamonti D, Johnson PC, Spetzler RF, Hadley MN, Drayer BP. Cavernous malformations and capillary telangiectasia: a spectrum
within a single pathological entity. Neurosurgery 1991;28:60-4. PubMed
28. Lee RR, Becher MW, Benson ML, Rigamonti D. Brain capillary telangiectasia: MR imaging appearance and clinicohistopathologic
findings. Radiology 1997;205:797-805. DOI PubMed
29. Naff NJ, Wemmer J, Hoenig-Rigamonti K, Rigamonti DR. A longitudinal study of patients with venous malformations: documentation
of a negligible hemorrhage risk and benign natural history. Neurology 1998;50:1709-14. DOI PubMed
30. Clatterbuck RE, Moriarity JL, Elmaci I, Lee RR, Breiter SN, Rigamonti D. Dynamic nature of cavernous malformations: a prospective
magnetic resonance imaging study with volumetric analysis. J Neurosurg 2000;93:981-6. DOI PubMed
31. Moriarity JL, Clatterbuck RE, Rigamonti D. The natural history of cavernous malformations. Neurosurg Clin N Am 1999;10:411-7.
PubMed
32. Moriarity JL, Wetzel M, Clatterbuck RE, et al. The natural history of cavernous malformations: a prospective study of 68 patients.
Neurosurgery 1999;44:1166-71. PubMed
33. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-
brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 2001;71:188-92. DOI
PubMed PMC
34. Clatterbuck RE, Elmaci I, Rigamonti D. The nature and fate of punctate (Type IV) cavernous malformations. Neurosurgery
2001;49:26-32. DOI PubMed
35. Kharkar S, Shuck J, Conway J, Rigamonti D. The natural history of conservatively managed symptomatic intramedullary spinal cord
cavernomas. Neurosurgery 2007;60:865-72; discussion 865. DOI PubMed
36. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol
2009;5:659-70. DOI PubMed
37. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study.
J Neurosurg 1994;80:422-32. DOI PubMed
38. Souza JM, Domingues RC, Cruz LC Jr, Domingues FS, Iasbeck T, Gasparetto EL. Susceptibility-weighted imaging for the evaluation
of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences.
AJNR Am J Neuroradiol 2008;29:154-8. DOI PubMed PMC
39. Rivera PP, Willinsky RA, Porter PJ. Intracranial cavernous malformations. Neuroimaging Clin N Am 2003;13:27-40. DOI PubMed
40. Li KW, Haroun RI, Clatterbuck RE, Murphy K, Rigamonti D. Superficial siderosis associated with multiple cavernous malformations:
report of three cases. Neurosurgery 2001;48:1147-51. DOI PubMed
41. Beechar VB, Srinivasan VM, Reznik OE, et al. Intraventricular cavernomas of the third ventricle: report of 2 cases and a systematic
review of the literature. World Neurosurg 2017;105:935-943.e3. DOI PubMed
42. Detwiler PW, Porter RW, Zabramski JM, Spetzler RF. De novo formation of a central nervous system cavernous malformation:
implications for predicting risk of hemorrhage. Case report and review of the literature. J Neurosurg 1997;87:629-32. DOI PubMed
43. Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous
system after radiation therapy. Neurosurg Focus 2006;21:e4. DOI PubMed
44. Rosenblum JS, Nazari M, Al-Khalili Y, Potigailo V, Veznedaroglu E. Unilateral symptomatic hypertrophic olivary degeneration
secondary to midline brainstem cavernous angioma: a case report and review of the literature. World Neurosurg 2018;110:294-300.
DOI PubMed
45. Rigamonti D, Hadley MN, Drayer BP, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med
1988;319:343-7. DOI PubMed
46. Flemming KD, Bovis GK, Meyer FB. Aggressive course of multiple de novo cavernous malformations. J Neurosurg 2011;115:1175-8.
DOI PubMed
47. Gastelum E, Sear K, Hills N, et al. Rates and characteristics of radiographically detected intracerebral cavernous malformations after
cranial radiation therapy in pediatric cancer patients. J Child Neurol 2015;30:842-9. DOI PubMed PMC
48. Clatterbuck RE, Elmací I, Rigamonti D. The juxtaposition of a capillary telangiectasia, cavernous malformation, and developmental
venous anomaly in the brainstem of a single patient: case report. Neurosurgery 2001;49:1246-50. DOI PubMed
49. Clatterbuck RE, Cohen B, Gailloud P, Murphy K, Rigamonti D. Vertebral hemangiomas associated with familial cerebral cavernous
malformation: segmental disease expression. Case report. J Neurosurg 2002;97:227-30. DOI PubMed
50. Polymeropoulos MH, Hurko O, Hsu F, et al. Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in
four families of Mexican-American descent. Neurology 1997;48:752-7. DOI PubMed
51. Zhang J, Clatterbuck RE, Rigamonti D, Dietz HC. Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery
2000;46:1272-7; discussion 1277. DOI PubMed